Filter
2226
Filtered Results: 2226
Text search:
drug
interactions
Featured
Recommendations
216
New Publications
543
Language
Document type
No document type
1442
Studies & Reports
275
Guidelines
275
Manuals
100
Strategic & Response Plan
50
Training Material
40
Fact sheets
31
Situation Updates
9
Resource Platforms
2
Infographics
2
Countries / Regions
India
128
Kenya
71
Global
70
South Africa
61
Ethiopia
49
Western and Central Europe
48
Nigeria
44
Nepal
43
Uganda
42
Tanzania
39
Sierra Leone
35
Malawi
35
Liberia
33
Latin America and the Carribbean
29
Zambia
29
Africa
28
Ghana
27
Bangladesh
26
Ukraine
23
Myanmar / Burma
22
Rwanda
21
Namibia
21
Eastern Europe
19
Cambodia
16
Russia
16
Lesotho
15
Philippines
15
Botswana
15
South–East Asia Region
14
Zimbabwe
11
Asia
11
Congo, Democratic Republic of
11
Eswatini/ Swaziland
9
Syria
8
Mozambique
8
USA
8
West and Central Africa
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
Indonesia
7
Germany
6
Tajikistan
5
East and Southern Africa
5
Brazil
5
South Sudan
5
Thailand
4
Afghanistan
4
Haiti
4
Georgia
4
Pakistan
4
Chile
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Guinea
3
Western Pacific Region
3
United Kingdom
3
Vietnam
3
North Macedonia
2
Colombia
2
Kazakhstan
2
Senegal
2
Kyrgyzstan
2
Peru
2
Armenia
2
North America
2
Southern Africa
2
Argentina
2
Sri Lanka
2
Sudan
2
Yemen
2
Iraq
2
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Gambia
1
China
1
Iran
1
Canada
1
Estonia
1
Austria
1
Qatar
1
Venezuela
1
Ireland
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Palestine
1
Libya
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
765
Clinical Guidelines
237
Public Health
132
Women & Child Health
71
Capacity Building
48
Key Resources
35
Pharmacy & Technologies
11
Toolboxes
Mental Health
326
HIV
260
TB
227
COVID-19
97
AMR
87
Pharmacy
62
NTDs
59
NCDs
50
Caregiver
44
Disability
39
Planetary Health
38
Ebola
32
Global Health Education
30
Rapid Response
28
Refugee
20
Conflict
13
Polio
10
Specific Hazards
8
Social Ethics
8
Health Financing Toolbox
6
Natural Hazards
5
Cholera
5
Zika
2
Med J DY Patil Univ 2017;10:229-33
Hypertension and COVID-19: Scientific report - 17 June 2021
Updated Guidelines
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
The Department of Health (DOH) has developed a National Integrated Sexual and Reproductive Health and Rights (SRHR) Policy.1 This policy addresses the many cross-cutting issues relating to SRH service provision, drawing together the principles, rights, and guidance for planning and implementation th...
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
The document discusses the complexities of managing patients with COPD and multiple comorbidities, highlighting the importance of personalized care and the appropriate use of inhaled corticosteroids (ICS). It outlines common comorbidities, such as asthma, osteoporosis, and diabetes, and offers guida...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Miscellaneous
Chapter J.2
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po...
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
